Which factors determine the extent and nature of monitoring?

• A. The objective, purpose, design, complexity, blinding, size, and endpoints of the trial
• B. The sponsor's preference
• C. The trial's country
• D. The investigators' personal schedules

Answer: (A)

Monitoring is driven by risk-based assessment of the trial, guided by the study’s objective and purpose, design, complexity, blinding, size, and endpoints. These factors determine what data are critical, where risks to participant safety or data integrity are greatest, and how intensively monitoring should be applied. For example, a straightforward trial with objective, hard endpoints may require less intensive monitoring, while a large, multicenter trial with a complex design, potential for bias, and multiple endpoints demands a more robust plan with centralized and/or on-site monitoring and verification activities. Logistics and feasibility, such as sponsor preferences, country-specific regulations, or investigators’ schedules, can influence how monitoring is carried out but do not set the level or scope of monitoring needed to protect subjects and ensure reliable data.